Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bipolar disorder and somatic diseases: Focus on oxidative stress markers.

Neuroscience applied·2026
Same author

Profiling tRNA-derived fragments in LPS-induced microglia and their influence on immune response.

Brain research·2026
Same author

Autophagy markers in umbilical cord blood-derived PBMCs and their association with preterm morbidities: a prospective multicenter cohort study.

BMJ paediatrics open·2026
Same author

Mitochondrial D-loop region methylation differentiates Parkinson's disease from atypical parkinsonism and Parkinson's disease dementia.

Epigenomics·2026
Same author

Deciphering the role of tRNA-derived fragments in neurological and psychiatric disease pathogenesis.

Frontiers in cellular neuroscience·2025
Same author

Mitochondrial Insights into Lithium Response in Bipolar Disorder: A State-of-the-Art Review.

Neuropsychobiology·2025

Related Experiment Videos

Inflammation in Parkinson's disease.

Kemal Ugur Tufekci1, Ralph Meuwissen, Sermin Genc

  • 1Department of Neuroscience, Health Science Institute, Dokuz Eylul University, Izmir, Turkey.

Advances in Protein Chemistry and Structural Biology
|July 21, 2012
PubMed
Summary

Neuroinflammation, involving glial cells and T cells, is a key factor in Parkinson's disease (PD) progression. Understanding these inflammatory mechanisms is crucial for developing targeted therapies to protect dopaminergic neurons.

Related Experiment Videos

Area of Science:

  • Neuroscience
  • Immunology

Background:

  • Parkinson's disease (PD) involves the degeneration of dopaminergic neurons.
  • Neuroinflammation, including glial activation and cytokine release, is a hallmark of PD pathogenesis.
  • Inflammatory processes are critical for disease progression, though not necessarily the primary cause.

Purpose of the Study:

  • To explore the role of neuroinflammation in Parkinson's disease pathogenesis.
  • To understand the mechanisms by which inflammatory responses contribute to neuronal loss.
  • To identify potential therapeutic targets within the inflammatory pathways of PD.

Main Methods:

  • Review of epidemiological, genetic, pharmacological, and imaging evidence.
  • Analysis of in vitro studies on microglial and astrocyte activation.
  • Consideration of findings from various animal models of PD.

Main Results:

  • Neuroinflammation significantly contributes to the progressive loss of dopaminergic neurons in PD.
  • Activated glial cells release toxic mediators implicated in disease progression.
  • In vitro studies suggest injured neurons trigger microglial and astrocyte activation.

Conclusions:

  • Neuroinflammation is a critical component of Parkinson's disease progression.
  • Further in vivo research is needed to fully elucidate the mechanisms involved.
  • Targeting inflammatory processes offers potential for novel therapeutic strategies in PD.